​

Bio-Techne (TECH) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Bio-Techne Revenue Highlights

Latest Revenue (Y)

$1.22B

Latest Revenue (Q)

$295.88M

Main Segment (Y)

Consumables

Main Geography (Y)

U S

Bio-Techne Revenue by Period

Bio-Techne Revenue by Year

DateRevenueChange
2026-06-30$1.22B-0.38%
2025-06-30$1.22B5.23%
2024-06-30$1.16B1.97%
2023-06-30$1.14B2.81%
2022-06-30$1.11B18.75%
2021-06-30$931.03M26.04%
2020-06-30$738.69M3.46%
2019-06-30$714.01M11.04%
2018-06-30$642.99M14.21%
2017-06-30$563.00M12.82%
2016-06-30$499.02M10.34%
2015-06-30$452.25M26.41%
2014-06-30$357.76M15.19%
2013-06-30$310.57M-1.27%
2012-06-30$314.56M8.48%
2011-06-30$289.96M7.77%
2010-06-30$269.05M1.93%
2009-06-30$263.96M2.54%
2008-06-30$257.42M15.19%
2007-06-30$223.48M10.30%
2006-06-30$202.62M13.41%
2005-06-30$178.65M10.79%
2004-06-30$161.26M11.20%
2003-06-30$145.01M10.78%
2002-06-30$130.90M13.47%
2001-06-30$115.36M11.09%
2000-06-30$103.84M14.23%
1999-06-30$90.90M35.07%
1998-06-30$67.30M10.51%
1997-06-30$60.90M11.54%
1996-06-30$54.60M14.47%
1995-06-30$47.70M18.36%
1994-06-30$40.30M40.42%
1993-06-30$28.70M-

Bio-Techne generated $1.22B in revenue during NA 2026, up -0.38% compared to the previous quarter, and up 130.50% compared to the same period a year ago.

Bio-Techne Revenue by Quarter

DateRevenueChange
2025-12-31$295.88M3.25%
2025-09-30$286.56M-9.59%
2025-06-30$316.96M0.25%
2025-03-31$316.18M6.45%
2024-12-31$297.03M2.62%
2024-09-30$289.46M-5.44%
2024-06-30$306.10M0.88%
2024-03-31$303.43M11.31%
2023-12-31$272.60M-1.57%
2023-09-30$276.94M-8.09%
2023-06-30$301.32M2.44%
2023-03-31$294.15M8.31%
2022-12-31$271.58M0.71%
2022-09-30$269.65M-6.44%
2022-06-30$288.23M-0.74%
2022-03-31$290.38M7.84%
2021-12-31$269.28M4.48%
2021-09-30$257.72M-0.51%
2021-06-30$259.03M6.35%
2021-03-31$243.55M8.61%
2020-12-31$224.25M9.82%
2020-09-30$204.20M16.13%
2020-06-30$175.83M-9.68%
2020-03-31$194.68M5.27%
2019-12-31$184.93M0.92%
2019-09-30$183.24M-4.39%
2019-06-30$191.66M3.68%
2019-03-31$184.86M5.93%
2018-12-31$174.51M7.08%
2018-09-30$162.97M-9.59%
2018-06-30$180.25M9.93%
2018-03-31$163.97M6.37%
2017-12-31$154.15M6.60%
2017-09-30$144.61M-7.64%
2017-06-30$156.58M8.71%
2017-03-31$144.04M9.28%
2016-12-31$131.81M0.94%
2016-09-30$130.58M-3.10%
2016-06-30$134.76M2.89%
2016-03-31$130.97M8.33%
2015-12-31$120.91M7.59%
2015-09-30$112.38M-4.49%
2015-06-30$117.66M3.07%
2015-03-31$114.16M1.97%
2014-12-31$111.95M3.20%
2014-09-30$108.48M17.24%
2014-06-30$92.52M-3.17%
2014-03-31$95.56M13.73%
2013-12-31$84.02M-1.93%
2013-09-30$85.67M7.79%
2013-06-30$79.47M-1.87%
2013-03-31$80.99M7.87%
2012-12-31$75.08M0.08%
2012-09-30$75.03M-4.65%
2012-06-30$78.68M-5.91%
2012-03-31$83.62M12.00%
2011-12-31$74.66M-3.78%
2011-09-30$77.60M-0.57%
2011-06-30$78.04M2.32%
2011-03-31$76.27M12.65%
2010-12-31$67.71M-0.35%
2010-09-30$67.94M1.85%
2010-06-30$66.71M-5.07%
2010-03-31$70.28M7.26%
2009-12-31$65.52M-1.52%
2009-09-30$66.53M2.53%
2009-06-30$64.89M-4.39%
2009-03-31$67.87M9.68%
2008-12-31$61.88M-10.74%
2008-09-30$69.32M2.29%
2008-06-30$67.77M-2.52%
2008-03-31$69.52M-

Bio-Techne generated $295.88M in revenue during Q2 2026, up 3.25% compared to the previous quarter, and up 102.22% compared to the same period a year ago.

Bio-Techne Revenue Breakdown

Bio-Techne Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceJun 26Jun 25Jun 24Jun 23
Instruments$110.63M$112.09M$108.27M$112.08M
Consumables$985.12M$972.29M$928.18M$917.73M
Royalty$24.99M$23.69M$23.34M$21.10M

Bio-Techne's latest annual revenue breakdown by segment (product or service), as of Jun 26: Consumables (87.90%), Instruments (9.87%), and Royalty (2.23%).

Quarterly Revenue by Product

Product/ServiceJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23
Instruments$31.54M$27.66M$29.61M$21.83M$28.90M$26.11M$30.87M$26.21M$27.09M$26.49M$29.82M
Consumables$260.73M$257.34M$235.44M$231.60M$252.94M$257.79M$230.72M$230.84M$245.78M$246.73M$211.13M
Royalty$5.87M$4.97M$8.51M$5.65M$5.51M$5.04M$8.10M$5.05M$5.05M$4.70M$7.52M
Product and Services---------$298.73M$265.08M
Service---------$25.50M$24.13M

Bio-Techne's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Consumables (87.45%), Instruments (10.58%), and Royalty (1.97%).

Bio-Techne Revenue Breakdown by Country

Annual Revenue by Country

CountryJun 26Jun 25Jun 24Jun 23
Rest Of World$39.28M$37.55M$36.50M$37.49M
UNITED KINGDOM$56.28M$54.83M--
U S$635.37M$683.23M$657.75M$642.47M
APAC, excluding Greater China$85.81M$77.26M$73.90M$73.19M
C N$104.06M$100.46M$99.47M$113.87M
Europe$294.22M$266.31M$241.43M$220.23M
United Kingdom--$50.01M$49.46M

Bio-Techne's latest annual revenue breakdown by geography, as of Jun 26: U S (52.29%), Europe (24.22%), C N (8.56%), APAC, excluding Greater China (7.06%), UNITED KINGDOM (4.63%), and Rest Of World (3.23%).

Quarterly Revenue by Country

CountryJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23
C N$26.91M$26.01M$26.35M$24.79M$26.91M$24.48M$23.93M$25.60M---
Rest Of World$11.32M$7.77M$11.14M$9.05M$9.65M$9.18M$9.73M$8.99M$10.05M$10.61M-
Europe$80.29M$73.45M$75.35M$65.13M$70.35M$66.50M$63.56M$60.53M---
UNITED KINGDOM$14.46M$14.89M$13.73M$13.21M$14.79M$12.85M-----
U S$166.10M$167.48M$146.56M$155.24M$176.39M$181.92M$177.53M$173.31M---
APAC, excluding Greater China$22.11M$21.82M$22.74M$19.15M$18.89M$21.25M$19.01M$18.12M$19.26M$18.25M$19.04M
United Kingdom--------$11.77M$15.12M-
EMEA, excluding United Kingdom---------$60.53M$62.54M
Greater China---------$25.60M$24.46M
Rest of World---------$10.61M$8.09M
United States---------$173.31M$147.79M

Bio-Techne's latest quarterly revenue breakdown by geography, as of Jun 26: U S (51.71%), Europe (25.00%), C N (8.38%), APAC, excluding Greater China (6.88%), UNITED KINGDOM (4.50%), and Rest Of World (3.53%).

Bio-Techne Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
JAZZJazz Pharmaceuticals$4.27B$1.21B
BMRNBioMarin Pharmaceutical$3.22B$989.71M
EXELExelixis$2.32B$628.69M
QGENQiagen$1.97B$458.80M
MRNAModerna$1.94B$145.00M
TECHBio-Techne$1.22B$295.88M
MDGLMadrigal Pharmaceuticals$958.40M$364.25M
CORTCorcept Therapeutics$761.41M$256.15M
CAICaris Life Sciences$294.01M$263.71M
RNAAtrium Therapeutics$18.75M$12.47M
RVMDRevolution Medicines--

TECH Revenue FAQ

What is Bio-Techne’s yearly revenue?

Bio-Techne's yearly revenue for 2026 was $1.22B, representing a decrease of -0.38% compared to 2025. The company's yearly revenue for 2025 was $1.22B, representing an increase of 5.23% compared to 2024. TECH's yearly revenue for 2024 was $1.16B, representing an increase of 1.97% compared to 2023.

What is Bio-Techne’s quarterly revenue?

Bio-Techne's quarterly revenue for Q2 2026 was $295.88M, a 3.25% increase from the previous quarter (Q1 2026), and a -0.39% decrease year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $286.56M, a -9.59% decrease from the previous quarter (Q4 2025), and a -1.00% decrease year-over-year (Q1 2025). TECH's quarterly revenue for Q4 2025 was $316.96M, a 0.25% increase from the previous quarter (Q3 2025), and a 3.55% increase year-over-year (Q4 2024).

What is Bio-Techne’s revenue growth rate?

Bio-Techne's revenue growth rate for the last 3 years (2024-2026) was 4.83%, and for the last 5 years (2022-2026) was 9.90%.

What are Bio-Techne’s revenue streams?

Bio-Techne's revenue streams in n 26 are Instruments, Consumables, and Royalty. Instruments generated $110.63M in revenue, accounting 9.87% of the company's total revenue, down -1.30% year-over-year. Consumables generated $985.12M in revenue, accounting 87.90% of the company's total revenue, up 1.32% year-over-year. Royalty generated $24.99M in revenue, accounting 2.23% of the company's total revenue, up 5.48% year-over-year.

What is Bio-Techne’s main source of revenue?

For the fiscal year ending Jun 26, the largest source of revenue of Bio-Techne was Consumables. This segment made a revenue of $985.12M, representing 87.90% of the company's total revenue.